HCA
HCA Healthcare, Inc.
Price Chart
Latest Quote
$390.39
+3.47 (+0.90%)
Current Price
| Previous Close | $386.92 |
| Open | $386.52 |
| Day High | $393.00 |
| Day Low | $384.55 |
| Volume | 609,977 |
Stock Information
| Quarterly Dividend / Yield | $3.12 / 0.81% |
| Shares Outstanding | 221.84M |
| Quarterly Dividend Yield | 0.81% |
| Quarterly Dividend | $3.12 |
| Total Debt | $49.84B |
| Cash Equivalents | $1.06B |
| Revenue | $76.39B |
| Net Income | $6.79B |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $86.61B |
| P/E Ratio | 13.45 |
| EPS (TTM) | $29.02 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $137.94B |
| Sales | $76.39B |
| Income | $6.79B |
| Book/sh | $-28.32 |
| Cash/sh | $4.80 |
| Employees | 230K |
Financial Ratios
| Quick Ratio | 0.64 |
| Current Ratio | 0.83 |
| EPS Growth TTM | 0.60% |
Returns & Margins
| ROA | 12.34% |
| Gross Margin | 41.61% |
| Operating Margin | 14.98% |
| Profit Margin | 8.89% |
Ownership
| Insider Ownership | 16.21% |
| Institutional Ownership | 78.31% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 11.80 |
| PEG | 1.14 |
| P/S | 1.13 |
| P/B | -13.78 |
Analyst Data
| Recommendation | buy |
| Target Price | $500.29 |
Technical Indicators
| SMA20 | $377.99 |
| SMA50 | $413.82 |
| SMA200 | $458.54 |
| RSI | 64.10 |
| ATR | 11.3839 |
| Shares Float | 149.49M |
| Short Float | 3.57% |
| Short Ratio | 3.60 |
| Volatility | 1.13 |
| Rel Volume | 0.35 |
Performance History
| Week | -1.65% |
| Month | -0.73% |
| Quarter | -19.46% |
| 6 Months | -17.17% |
| YTD | -16.72% |
| Year | +3.78% |
| 3 Years | +37.76% |
| 5 Years | +96.90% |
| 10 Years | +449.33% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $390.39 | 609,977 |
| 2026-06-23 | $386.92 | 1,107,500 |
| 2026-06-22 | $376.99 | 1,632,500 |
| 2026-06-18 | $375.17 | 2,656,800 |
| 2026-06-17 | $388.16 | 1,462,200 |
| 2026-06-16 | $396.93 | 1,499,500 |
| 2026-06-15 | $389.19 | 1,883,700 |
| 2026-06-12 | $386.41 | 1,811,000 |
| 2026-06-11 | $377.75 | 1,672,200 |
| 2026-06-10 | $372.59 | 1,920,500 |
| 2026-06-09 | $374.15 | 1,663,100 |
| 2026-06-08 | $360.60 | 1,610,900 |
| 2026-06-05 | $371.39 | 2,185,900 |
| 2026-06-04 | $361.11 | 1,891,400 |
| 2026-06-03 | $362.50 | 2,212,200 |
| 2026-06-02 | $366.62 | 1,999,700 |
| 2026-06-01 | $370.22 | 2,397,500 |
| 2026-05-29 | $377.78 | 2,352,600 |
| 2026-05-28 | $383.62 | 1,603,100 |
| 2026-05-27 | $391.37 | 975,700 |
| 2026-05-26 | $391.64 | 1,091,700 |
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
đ° Latest News
Has Community Health Found the Right Prescription for its Debt Burden?
Zacks âĸ 2026-06-23T16:13:00Z
Hospital Chains Stocks Q1 Teardown: HCA Healthcare (NYSE:HCA) Vs The Rest
StockStory âĸ 2026-06-22T19:47:19Z
The Medicare Crisis for Insurers Is Over. The Easy Gains Are Too.
The Wall Street Journal âĸ 2026-06-17T09:30:00Z
1 S&P 500 Stock on Our Buy List and 2 We Brush Off
StockStory âĸ 2026-06-16T10:57:04Z
Healthcare Added 35,200 Jobsâ3 Stocks Positioned to Benefit
MarketBeat âĸ 2026-06-15T13:50:00Z
Is HCA Healthcare Stock A Trap Or A Missed Opportunity?
Trefis âĸ 2026-06-11T23:04:19Z
Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027
Insider Monkey âĸ 2026-06-11T13:03:34Z
HCA Healthcare Expands Into Education And India As Valuation Gap Widens
Simply Wall St. âĸ 2026-06-11T12:17:59Z
Likely Sector ETF & Stock Winners From May Jobs Report
Zacks âĸ 2026-06-10T14:00:00Z
HCA Healthcare (HCA) Announces Agreement to Acquire The College of Health Care Professions
Insider Monkey âĸ 2026-06-09T17:41:27Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $44,226,000,000 | $41,925,000,000 | $39,389,000,000 | $37,056,000,000 |
| Cost Of Revenue | $44,226,000,000 | $41,925,000,000 | $39,389,000,000 | $37,056,000,000 |
| Total Revenue | $75,600,000,000 | $70,603,000,000 | $64,968,000,000 | $60,233,000,000 |
| Operating Revenue | $73,142,000,000 | $68,061,000,000 | $61,894,000,000 | $56,719,000,000 |
| Expenses | ||||
| Interest Expense | $2,248,000,000 | $2,061,000,000 | $1,938,000,000 | $1,741,000,000 |
| Total Expenses | $63,635,000,000 | $60,056,000,000 | $55,341,000,000 | $51,180,000,000 |
| Other Income Expense | $115,000,000 | $37,000,000 | $17,000,000 | $1,268,000,000 |
| Net Non Operating Interest Income Expense | $-2,248,000,000 | $-2,061,000,000 | $-1,938,000,000 | $-1,741,000,000 |
| Interest Expense Non Operating | $2,248,000,000 | $2,061,000,000 | $1,938,000,000 | $1,741,000,000 |
| Operating Expense | $19,409,000,000 | $18,131,000,000 | $15,952,000,000 | $14,124,000,000 |
| Other Operating Expenses | $15,886,000,000 | $14,819,000,000 | $12,875,000,000 | $11,155,000,000 |
| General And Administrative Expense | - | $31,170,000,000 | $29,487,000,000 | $27,685,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $6,784,000,000 | $5,760,000,000 | $5,242,000,000 | $5,643,000,000 |
| Net Interest Income | $-2,248,000,000 | $-2,061,000,000 | $-1,938,000,000 | $-1,741,000,000 |
| Normalized Income | $6,754,733,000 | $5,749,066,000 | $5,245,950,000 | $4,668,269,000 |
| Net Income From Continuing And Discontinued Operation | $6,784,000,000 | $5,760,000,000 | $5,242,000,000 | $5,643,000,000 |
| Net Income Common Stockholders | $6,784,000,000 | $5,760,000,000 | $5,242,000,000 | $5,643,000,000 |
| Net Income | $6,784,000,000 | $5,760,000,000 | $5,242,000,000 | $5,643,000,000 |
| Net Income Including Noncontrolling Interests | $7,782,000,000 | $6,657,000,000 | $6,091,000,000 | $6,834,000,000 |
| Net Income Continuous Operations | $7,782,000,000 | $6,657,000,000 | $6,091,000,000 | $6,834,000,000 |
| Pretax Income | $9,832,000,000 | $8,523,000,000 | $7,706,000,000 | $8,580,000,000 |
| Special Income Charges | $37,000,000 | $14,000,000 | $-5,000,000 | $1,223,000,000 |
| Earnings From Equity Interest | $78,000,000 | $23,000,000 | $22,000,000 | $45,000,000 |
| Operating Income | $11,965,000,000 | $10,547,000,000 | $9,627,000,000 | $9,053,000,000 |
| Depreciation Amortization Depletion Income Statement | $3,523,000,000 | $3,312,000,000 | $3,077,000,000 | $2,969,000,000 |
| Depreciation And Amortization In Income Statement | $3,523,000,000 | $3,312,000,000 | $3,077,000,000 | $2,969,000,000 |
| Gross Profit | $31,374,000,000 | $28,678,000,000 | $25,579,000,000 | $23,177,000,000 |
| Per Share | ||||
| Diluted EPS | $28.33 | $22.00 | $18.97 | $19.15 |
| Basic EPS | $30.20 | $23.04 | $19.74 | $19.43 |
| Other | ||||
| Tax Effect Of Unusual Items | $7,733,000 | $3,066,000 | $-1,050,000 | $248,269,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $15,566,000,000 | $13,882,000,000 | $12,726,000,000 | $12,067,000,000 |
| Total Unusual Items | $37,000,000 | $14,000,000 | $-5,000,000 | $1,223,000,000 |
| Total Unusual Items Excluding Goodwill | $37,000,000 | $14,000,000 | $-5,000,000 | $1,223,000,000 |
| Reconciled Depreciation | $3,523,000,000 | $3,312,000,000 | $3,077,000,000 | $2,969,000,000 |
| EBITDA (Bullshit earnings) | $15,603,000,000 | $13,896,000,000 | $12,721,000,000 | $13,290,000,000 |
| EBIT | $12,080,000,000 | $10,584,000,000 | $9,644,000,000 | $10,321,000,000 |
| Diluted Average Shares | $239,495,000 | $261,806,000 | $276,412,000 | $294,666,000 |
| Basic Average Shares | $224,605,100 | $249,981,400 | $265,537,300 | $290,348,000 |
| Diluted NI Availto Com Stockholders | $6,784,000,000 | $5,760,000,000 | $5,242,000,000 | $5,643,000,000 |
| Minority Interests | $-998,000,000 | $-897,000,000 | $-849,000,000 | $-1,191,000,000 |
| Tax Provision | $2,050,000,000 | $1,866,000,000 | $1,615,000,000 | $1,746,000,000 |
| Gain On Sale Of Business | $37,000,000 | $14,000,000 | $-5,000,000 | $1,301,000,000 |
| Selling General And Administration | - | $31,170,000,000 | $29,487,000,000 | $27,685,000,000 |
| Salaries And Wages | - | $31,170,000,000 | $29,487,000,000 | $27,685,000,000 |
| Gain On Sale Of Ppe | - | - | - | $1,301,000,000 |
| Other Special Charges | - | - | - | $78,000,000 |
Fetched: 2026-06-11
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-16,320,000,000 | $-12,592,000,000 | $-11,719,000,000 | $-12,420,000,000 |
| Total Assets | $60,720,000,000 | $59,513,000,000 | $56,211,000,000 | $52,438,000,000 |
| Total Non Current Assets | $44,937,000,000 | $43,099,000,000 | $41,284,000,000 | $38,795,000,000 |
| Other Non Current Assets | $255,000,000 | $230,000,000 | $184,000,000 | $298,000,000 |
| Goodwill And Other Intangible Assets | $10,293,000,000 | $10,093,000,000 | $9,945,000,000 | $9,653,000,000 |
| Current Assets | $15,783,000,000 | $16,414,000,000 | $14,927,000,000 | $13,643,000,000 |
| Other Current Assets | $2,224,000,000 | $1,992,000,000 | $2,013,000,000 | $1,776,000,000 |
| Inventory | $1,652,000,000 | $1,738,000,000 | $2,021,000,000 | $2,068,000,000 |
| Receivables | $10,867,000,000 | $10,751,000,000 | $9,958,000,000 | $8,891,000,000 |
| Accounts Receivable | $10,867,000,000 | $10,751,000,000 | $9,958,000,000 | $8,891,000,000 |
| Cash Cash Equivalents And Short Term Investments | $1,040,000,000 | $1,933,000,000 | $935,000,000 | $908,000,000 |
| Cash And Cash Equivalents | $1,040,000,000 | $1,933,000,000 | $935,000,000 | $908,000,000 |
| Debt | ||||
| Net Debt | $45,452,000,000 | $41,098,000,000 | $38,658,000,000 | $37,176,000,000 |
| Total Debt | $48,697,000,000 | $45,237,000,000 | $41,859,000,000 | $40,200,000,000 |
| Long Term Debt And Capital Lease Obligation | $43,456,000,000 | $40,196,000,000 | $39,072,000,000 | $39,466,000,000 |
| Long Term Debt | $41,603,000,000 | $38,333,000,000 | $37,169,000,000 | $37,714,000,000 |
| Current Debt And Capital Lease Obligation | $5,241,000,000 | $5,041,000,000 | $2,787,000,000 | $734,000,000 |
| Current Debt | $4,889,000,000 | $4,698,000,000 | $2,424,000,000 | $370,000,000 |
| Other Current Borrowings | $4,889,000,000 | $4,698,000,000 | $2,424,000,000 | $370,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $63,491,000,000 | $58,958,000,000 | $55,151,000,000 | $52,511,000,000 |
| Total Non Current Liabilities Net Minority Interest | $47,141,000,000 | $43,781,000,000 | $42,496,000,000 | $42,609,000,000 |
| Other Non Current Liabilities | $3,685,000,000 | $3,585,000,000 | $3,424,000,000 | $3,143,000,000 |
| Current Liabilities | $16,350,000,000 | $15,177,000,000 | $12,655,000,000 | $9,902,000,000 |
| Payables And Accrued Expenses | $10,130,000,000 | $9,226,000,000 | $9,001,000,000 | $8,374,000,000 |
| Interest Payable | $499,000,000 | $502,000,000 | $414,000,000 | $402,000,000 |
| Payables | $5,163,000,000 | $4,695,000,000 | $4,615,000,000 | $4,610,000,000 |
| Total Tax Payable | $504,000,000 | $419,000,000 | $382,000,000 | $371,000,000 |
| Accounts Payable | $4,659,000,000 | $4,276,000,000 | $4,233,000,000 | $4,239,000,000 |
| Tradeand Other Payables Non Current | - | - | $1,867,000,000 | $1,615,000,000 |
| Equity | ||||
| Common Stock Equity | $-6,027,000,000 | $-2,499,000,000 | $-1,774,000,000 | $-2,767,000,000 |
| Total Equity Gross Minority Interest | $-2,771,000,000 | $555,000,000 | $1,060,000,000 | $-73,000,000 |
| Stockholders Equity | $-6,027,000,000 | $-2,499,000,000 | $-1,774,000,000 | $-2,767,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-305,000,000 | $-387,000,000 | $-425,000,000 | $-490,000,000 |
| Other Equity Adjustments | $-305,000,000 | $-387,000,000 | $-425,000,000 | $-490,000,000 |
| Retained Earnings | $-5,724,000,000 | $-2,115,000,000 | $-1,352,000,000 | $-2,280,000,000 |
| Long Term Equity Investment | $1,118,000,000 | $1,231,000,000 | $1,233,000,000 | $1,204,000,000 |
| Investments In Other Ventures Under Equity Method | $633,000,000 | $662,000,000 | $756,000,000 | $823,000,000 |
| Other | ||||
| Ordinary Shares Number | $224,605,100 | $249,981,400 | $265,537,300 | $277,378,300 |
| Share Issued | $224,605,100 | $249,981,400 | $265,537,300 | $277,378,300 |
| Tangible Book Value | $-16,320,000,000 | $-12,592,000,000 | $-11,719,000,000 | $-12,420,000,000 |
| Invested Capital | $40,465,000,000 | $40,532,000,000 | $37,819,000,000 | $35,317,000,000 |
| Working Capital | $-567,000,000 | $1,237,000,000 | $2,272,000,000 | $3,741,000,000 |
| Capital Lease Obligations | $2,205,000,000 | $2,206,000,000 | $2,266,000,000 | $2,116,000,000 |
| Total Capitalization | $35,576,000,000 | $35,834,000,000 | $35,395,000,000 | $34,947,000,000 |
| Minority Interest | $3,256,000,000 | $3,054,000,000 | $2,834,000,000 | $2,694,000,000 |
| Capital Stock | $2,000,000 | $3,000,000 | $3,000,000 | $3,000,000 |
| Common Stock | $2,000,000 | $3,000,000 | $3,000,000 | $3,000,000 |
| Long Term Capital Lease Obligation | $1,853,000,000 | $1,863,000,000 | $1,903,000,000 | $1,752,000,000 |
| Current Capital Lease Obligation | $352,000,000 | $343,000,000 | $363,000,000 | $364,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $979,000,000 | $910,000,000 | $867,000,000 | $794,000,000 |
| Current Accrued Expenses | $4,967,000,000 | $4,531,000,000 | $4,386,000,000 | $3,764,000,000 |
| Investments And Advances | $1,118,000,000 | $1,231,000,000 | $1,233,000,000 | $1,204,000,000 |
| Investmentsin Subsidiariesat Cost | $485,000,000 | $569,000,000 | $477,000,000 | $381,000,000 |
| Net PPE | $33,271,000,000 | $31,545,000,000 | $29,922,000,000 | $27,640,000,000 |
| Accumulated Depreciation | $-35,134,000,000 | $-33,100,000,000 | $-30,833,000,000 | $-29,182,000,000 |
| Gross PPE | $68,405,000,000 | $64,645,000,000 | $60,755,000,000 | $56,822,000,000 |
| Construction In Progress | $2,145,000,000 | $1,858,000,000 | $1,870,000,000 | $1,756,000,000 |
| Other Properties | $39,119,000,000 | $36,801,000,000 | $34,205,000,000 | $32,046,000,000 |
| Buildings And Improvements | $23,726,000,000 | $22,691,000,000 | $21,560,000,000 | $20,221,000,000 |
| Land And Improvements | $3,415,000,000 | $3,295,000,000 | $3,120,000,000 | $2,799,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Investmentsin Associatesat Cost | - | - | $756,000,000 | $823,000,000 |
| Additional Paid In Capital | - | - | - | - |
Fetched: 2026-06-11
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $7,692,000,000 | $5,639,000,000 | $4,687,000,000 | $4,127,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $12,636,000,000 | $10,514,000,000 | $9,431,000,000 | $8,522,000,000 |
| Cash Flow From Continuing Operating Activities | $12,636,000,000 | $10,514,000,000 | $9,431,000,000 | $8,522,000,000 |
| Operating Gains Losses | $-37,000,000 | $-14,000,000 | $5,000,000 | $-1,223,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-4,944,000,000 | $-4,875,000,000 | $-4,744,000,000 | $-4,395,000,000 |
| Investing Cash Flow | $-4,988,000,000 | $-4,933,000,000 | $-5,317,000,000 | $-3,389,000,000 |
| Cash Flow From Continuing Investing Activities | $-4,988,000,000 | $-4,933,000,000 | $-5,317,000,000 | $-3,389,000,000 |
| Net Other Investing Changes | $12,000,000 | $-5,000,000 | $-19,000,000 | $-21,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-10,067,000,000 | $-6,042,000,000 | $-3,811,000,000 | $-7,000,000,000 |
| Financing Cash Flow | $-8,550,000,000 | $-4,582,000,000 | $-4,094,000,000 | $-5,656,000,000 |
| Cash Flow From Continuing Financing Activities | $-8,550,000,000 | $-4,582,000,000 | $-4,094,000,000 | $-5,656,000,000 |
| Net Other Financing Charges | $-1,091,000,000 | $-1,055,000,000 | $-917,000,000 | $-1,290,000,000 |
| Cash Dividends Paid | $-679,000,000 | $-690,000,000 | $-661,000,000 | $-653,000,000 |
| Common Stock Dividend Paid | $-679,000,000 | $-690,000,000 | $-661,000,000 | $-653,000,000 |
| Net Common Stock Issuance | $-10,067,000,000 | $-6,042,000,000 | $-3,811,000,000 | $-7,000,000,000 |
| Other | ||||
| Repayment Of Debt | $-7,389,000,000 | $-2,410,000,000 | $-909,000,000 | $-2,830,000,000 |
| Issuance Of Debt | $8,474,000,000 | $7,495,000,000 | $3,224,000,000 | $6,117,000,000 |
| Interest Paid Supplemental Data | $2,207,000,000 | $1,938,000,000 | $1,892,000,000 | $1,662,000,000 |
| Income Tax Paid Supplemental Data | $1,740,000,000 | $1,844,000,000 | $1,386,000,000 | $1,175,000,000 |
| End Cash Position | $1,040,000,000 | $1,933,000,000 | $935,000,000 | $908,000,000 |
| Beginning Cash Position | $1,933,000,000 | $935,000,000 | $908,000,000 | $1,451,000,000 |
| Effect Of Exchange Rate Changes | $9,000,000 | $-1,000,000 | $7,000,000 | $-20,000,000 |
| Changes In Cash | $-902,000,000 | $999,000,000 | $20,000,000 | $-523,000,000 |
| Common Stock Payments | $-10,067,000,000 | $-6,042,000,000 | $-3,811,000,000 | $-7,000,000,000 |
| Net Issuance Payments Of Debt | $3,287,000,000 | $3,205,000,000 | $1,295,000,000 | $3,287,000,000 |
| Net Short Term Debt Issuance | $2,202,000,000 | $-1,880,000,000 | $-1,020,000,000 | $120,000,000 |
| Net Long Term Debt Issuance | $1,085,000,000 | $5,085,000,000 | $2,315,000,000 | $3,287,000,000 |
| Long Term Debt Payments | $-7,389,000,000 | $-2,410,000,000 | $-909,000,000 | $-2,830,000,000 |
| Long Term Debt Issuance | $8,474,000,000 | $7,495,000,000 | $3,224,000,000 | $6,117,000,000 |
| Net Investment Purchase And Sale | $72,000,000 | $-115,000,000 | $-112,000,000 | $14,000,000 |
| Net Business Purchase And Sale | $-128,000,000 | $62,000,000 | $-442,000,000 | $1,013,000,000 |
| Sale Of Business | $269,000,000 | $328,000,000 | $193,000,000 | $1,237,000,000 |
| Purchase Of Business | $-397,000,000 | $-266,000,000 | $-635,000,000 | $-224,000,000 |
| Net PPE Purchase And Sale | $-4,944,000,000 | $-4,875,000,000 | $-4,744,000,000 | $-4,395,000,000 |
| Purchase Of PPE | $-4,944,000,000 | $-4,875,000,000 | $-4,744,000,000 | $-4,395,000,000 |
| Change In Working Capital | $418,000,000 | $-106,000,000 | $-457,000,000 | $-1,152,000,000 |
| Change In Payables And Accrued Expense | $666,000,000 | $359,000,000 | $604,000,000 | $-296,000,000 |
| Change In Inventory | $-154,000,000 | $334,000,000 | $-126,000,000 | $-59,000,000 |
| Change In Receivables | $-94,000,000 | $-799,000,000 | $-935,000,000 | $-797,000,000 |
| Changes In Account Receivables | $-94,000,000 | $-799,000,000 | $-935,000,000 | $-797,000,000 |
| Other Non Cash Items | $239,000,000 | $283,000,000 | $224,000,000 | $182,000,000 |
| Stock Based Compensation | $401,000,000 | $360,000,000 | $262,000,000 | $341,000,000 |
| Deferred Tax | $310,000,000 | $22,000,000 | $229,000,000 | $571,000,000 |
| Deferred Income Tax | $310,000,000 | $22,000,000 | $229,000,000 | $571,000,000 |
| Depreciation Amortization Depletion | $3,523,000,000 | $3,312,000,000 | $3,077,000,000 | $2,969,000,000 |
| Depreciation And Amortization | $3,523,000,000 | $3,312,000,000 | $3,077,000,000 | $2,969,000,000 |
| Gain Loss On Sale Of PPE | $-37,000,000 | $-14,000,000 | $5,000,000 | $-1,301,000,000 |
| Net Income From Continuing Operations | $7,782,000,000 | $6,657,000,000 | $6,091,000,000 | $6,834,000,000 |
Fetched: 2026-06-11